US 7060712
Crystalline form of aryl aniline β2 adrenergic receptor agonist
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7060712 (Crystalline form of aryl aniline β2 adrenergic receptor agonist) held by Theravance, Inc. expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P43/00